|
Volumn 3, Issue 4, 2003, Pages 187-188
|
HIV and testosterone therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ANABOLIC AGENT;
ANTIRETROVIRUS AGENT;
FLUCONAZOLE;
FOLLITROPIN;
LUTEINIZING HORMONE;
METHYLTESTOSTERONE;
OXYMETHOLONE;
PLACEBO;
RECOMBINANT GROWTH HORMONE;
TESTOSTERONE;
TESTOSTERONE DERIVATIVE;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
APPETITE;
BODY FAT;
BODY MASS;
CLINICAL TRIAL;
DIET SUPPLEMENTATION;
DRUG EFFECT;
DRUG POTENCY;
EXTRACELLULAR SPACE;
FOLLITROPIN BLOOD LEVEL;
HORMONE SUBSTITUTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LEAN BODY WEIGHT;
LIVER TOXICITY;
LUTEINIZING HORMONE BLOOD LEVEL;
META ANALYSIS;
MUSCLE WEAKNESS;
PARAMETER;
PATIENT SELECTION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SHORT SURVEY;
TESTOSTERONE BLOOD LEVEL;
VISUAL ANALOG SCALE;
WASTING SYNDROME;
WEIGHT GAIN;
|
EID: 0037382877
PISSN: 14733099
EISSN: None
Source Type: Journal
DOI: 10.1016/S1473-3099(03)00572-3 Document Type: Short Survey |
Times cited : (5)
|
References (8)
|